Browsing by Author "Abdel-Aziz, Mosaad"

Now showing 1 - 5 of 5

Furlow Palatoplasty and Tonsillectomy for Treating Patients With Submucous Cleft Palate and Tonsillar Hypertrophy: A One-Stage Procedure
(Springer, 2022-07) Abdel-Aziz, Mosaad; Abdel-Fattah, Gamal; Abdel-Aziz, Nada M; Sabry, Omar; Elsherbeeny, Motaz
re Favorites Permissions BRIEF CLINICAL STUDIES Furlow Palatoplasty and Tonsillectomy for Treating Patients With Submucous Cleft Palate and Tonsillar Hypertrophy: A One-Stage Procedure Abdel-Aziz, Mosaad MD*; Abdel-Fattah, Gamal MD†; Abdel-Aziz, Nada M. BDS‡; Sabry, Omar MD*; Elsherbeeny, Motaz MD* Author Information *Department of Otolaryngology, Kasr Alainy Faculty of Medicine, Cairo University †Department of Otolaryngology, Misr University for Science and Technology (MUST), Cairo ‡Faculty of Dentistry, October University of Modern Science and Arts, Giza, Egypt Address correspondence and reprint requests to Mosaad Abdel-Aziz, MD, 2 el-salam st., King Faisal, above el-baraka bank, Giza, Cairo, Egypt; E-mail: mosabeez@hotmail.com, mosabeez@cu.edu.eg, mosabeez@kasralainy.edu.eg The study protocol was approved by the research ethics committee of our institute. The authors report no conflicts of interest. Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.jcraniofacialsurgery.com. The Journal of Craniofacial Surgery: July 26, 2022 - Volume - Issue - 10.1097/SCS.0000000000008732 doi: 10.1097/SCS.0000000000008732 BUY SDC PAP Metrics Abstract Background: Children with cleft palate are more liable to have obstructive sleep apnea than children with normal palate due to narrow airways. Tonsillar hypertrophy is a common cause of pediatric obstructive sleep apnea; hence, it is not surprising to be encountered during cleft palate repair. The aim of this study was to evaluate the feasibility of tonsillectomy and Furlow palatoplasty performed as a 1-stage operation in patients presenting with submucous cleft palate (SMCP) and tonsillar hypertrophy. Materials and Methods: Eleven pediatric patients with SMCP and hypertrophied tonsils were included in this case series study. Furlow palatoplasty and tonsillectomy were performed for the patients in 1 sitting. The evaluation of velopharyngeal function was done preoperatively and postoperatively via auditory-perceptual-assessment, nasometry, and flexible nasopharyngoscopy. In addition, the Epworth sleepiness scale for children/adolescents was administered to the parents to assess daytime sleepiness of their children. Results: The speech improved postoperatively. Auditory-perceptual-assessment showed significant reductions in hypernasal speech, nasal air escape, and weak pressure consonants. In addition, nasometry revealed significantly decreased nasalance scores for nasal and oral sentences. A postoperative increased velar movement was observed with a significant improvement in velopharyngeal closure. The preoperative Epworth sleepiness scale for children/adolescents assessment revealed excessive daytime sleepiness in 8 patients, with significant improvement of scores postoperatively. Conclusions: Removal of hypertrophied tonsils during the repair of SMCP with Furlow palatoplasty did not negatively affect speech outcome or velar movement postoperatively. It is logical to perform both procedures simultaneously in 1 sitting to avoid postoperative sleep-related breathing disorder, which may necessitate a second stage operation.
Mucormycosis: A potential head and neck problem in COVID-19 patients
(John Wiley and Sons Inc, 19/01/2022) Abdel-Aziz, Mosaad; Azab, Noha; Abdel-Aziz, Nada M; Abdel-Aziz, Dina M
Mucormycosis is a rare fatal fungal infection that affects the nose and paranasal sinuses and may even extend to the orbit and the brain. The rhino-orbital-cerebral mucormycosis (ROCM) is the commonest form of Mucorales infection. The infection is usually transmitted by inhalation and causes tissue necrosis by angioinvasion and thrombosis.1 The disease has a rapid course causing ischemia and gangrene of the affected tissue, and it mainly affects immunocompromised patients.2 Before the pandemic of coronavirus disease 2019 (COVID-19), diagnosis of the disease was limited to individuals with low immunity such as patients with uncontrolled diabetes, end-stage renal diseases, hematologic malignancies, and/or organ transplantation. After the COVID-19 outbreak, many case reports of COVID-19-associated mucormycosis (CAM) have been published
Nasopharyngeal Polyp in a Patient With Submucous Cleft Palate
(CUREUS INC, PO BOX 61002, PALO ALTO, CA 94306 USA, 05/01/2021) Abdel-Aziz, Mosaad; Abdel-Fattah, Gamal; Abdel-Aziz, Nada M
Encountering a nasopharyngeal polyp in a patient with submucous cleft palate (SMCP) is a difficult problem, as the lesion could support the weak palate. Removal of this lesion may unmask the SMCP with consequent worsening of speech nasality. Nasal septal polyp protruding to the nasopharynx in a patient with SMCP has not been reported before in the literature. This report describes a septa! polyp arising from the posterior border of the nasal septum and protruding in the nasopharynx in a 16-year-old girl with submucous cleft palate. The polyp appeared to support the weak palate, and they acted as a ball and socket during speech articulation. Removal of this polyp may result in velopharyngeal insufficiency. Trans-nasal endoscopic removal of the polyp with obturation of the velopharyngeal port with a superiorly-based pharyngeal flap was performed in the same sitting. Pre- and postoperative speech evaluation using auditory perceptual assessment and nasometry revealed no worsening of nasality, also the patient reported improvement of her nasal breathing. We concluded that, the presence of a nasopharyngeal polyp in a patient with SMCP may compensate the speech problem. Removal of the polyp and treatment of SMCP by a pharyngeal flap in one-sitting is an effective procedure without adverse effect on patient's speech
Pediatric COVID-19 and the Factors That May Mitigate Its Clinical Course
(GEORG THIEME VERLAG KG, RUDIGERSTR 14, D-70469 STUTTGART, GERMANY, 10/15/2020) Abdel-Aziz, Mosaad; Abdel-Aziz, NadaM.; Abdel-Aziz, Dina M; Azab, Noha
The clinical manifestations of novel coronavirus disease 2019 (COVID-19) vary from mild flu-like symptoms to severe fatal pneumonia. However, children with COVID-19 may be asymptomatic or may have mild clinical symptoms. The aim of this study was to investigate clinical features of pediatric COVID-19 and to search for the factors that may mitigate the disease course. We reviewed the literature to realize the clinical features, laboratory, and radiographic data that may be diagnostic for COVID-19 among children. Also, we studied the factors that may affect the clinical course of the disease. Fever, dry cough, and fatigue are the main symptoms of pediatric COVID-19, sometimes flu-like symptoms and/or gastrointestinal symptoms may be present. Although some infected children may be asymptomatic, a recent unusual hyper-inflammatory reaction with overlapping features of Kawasaki's disease and toxic shock syndrome in pediatric COVID-19 has been occasionally reported. Severe acute respiratory syndrome-coronvirus-2 (SARS-CoV-2) nucleic acid testing is the cornerstone method for the diagnosis of COVID-19. Lymphocyte count and other inflammatory markers are not essentially diagnostic; however, chest computed tomography is highly specific. Factors that may mitigate the severity of pediatric COVID-19 are home confinement with limited children activity, trained immunity caused by compulsory vaccination, the response of the angiotensin-converting enzyme 2 receptors in children is not the same as in adults, and that children are less likely to have comorbidities. As infected children may be asymptomatic or may have only mild respiratory and/or gastrointestinal symptoms that might be missed, all children for families who have a member diagnosed with COVID-19 should be investigated.
Subjective Smell Assessment as An Office-based Rapid Procedure In COVID-19 Era
(Elsevier, 2020) Abdel-Aziz, Mosaad; Abdel-Aziz, Nada M.; Abdel-Aziz, Dina M.; Azab, Noha
A recent history of smell disorder may be a potential predictor for COVID-19. The authors used a subjective olfaction score that was demonstrated on a hard paper-bar. The authors examined 480 patients who were attending the outpatient clinic. Ninety-seven patients (20.2%) demonstrated variable degrees of recent smell disorder. For those patients, lab testing including nasopharyngeal swab for real-time polymerase chain reaction (RT-PCR) was performed. Eighty-eight of them (90.7%) have been confirmed to be COVID-19 positive. Although psychophysical testing is more reliable, subjective assessment of smell is a rapid procedure and can be used as an office-based method for patients’ screening in COVID-19 era. Smell disorder could be an alarming sign for COVID-19 even with absent characteristic symptom